148 results
Patient safety
Yes Remove Yes filter
-
List item
News: Hydroxyethyl-starch solutions for infusion recommended for suspension from the market (updated)
CMDh, Last updated: 26/07/2022 -
List item
News: EMA recommends restricting use of cancer medicine Rubraca (new)
CHMP, Last updated: 22/07/2022 -
List item
News: EMA recommends withdrawal of marketing authorisation for amfepramone medicines
PRAC, Last updated: 10/06/2022 -
List item
News: Synchron Research Service: suspension of medicines over flawed studies
CHMP, Last updated: 20/05/2022 -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022 -
List item
News: CHMP endorses review finding no link between viral vector in Zynteglo and blood cancer
CAT, CHMP, Last updated: 23/07/2021 -
List item
News: COVID-19 Vaccine Janssen: Guillain-Barré syndrome listed as a very rare side effect
PRAC, Last updated: 22/07/2021 -
List item
News: Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis
PRAC, Last updated: 09/07/2021 -
List item
News: EMA advises against use of COVID-19 Vaccine Janssen in people with history of capillary leak syndrome
PRAC, Last updated: 09/07/2021 -
List item
News: COVID-19 vaccines: update on ongoing evaluation of myocarditis and pericarditis
PRAC, Last updated: 11/06/2021 -
List item
News: Vaxzevria: EMA advises against use in people with history of capillary leak syndrome
PRAC, Last updated: 11/06/2021 -
List item
News: EMA raises awareness of clinical care recommendations to manage suspected thrombosis with thrombocytopenia syndrome
Last updated: 07/06/2021 -
List item
News: Vaxzevria: further advice on blood clots and low blood platelets
CHMP, Last updated: 21/05/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: benefits and risks in context
CHMP, Last updated: 23/04/2021 -
List item
News: COVID-19 Vaccine Janssen: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 20/04/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
CHMP, Last updated: 14/04/2021 -
List item
News: COVID-19 Vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
PRAC, Last updated: 14/04/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
PRAC, Last updated: 07/04/2021 -
List item
News: AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
PRAC, Last updated: 31/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca – Update on ongoing evaluation of blood clot cases
PRAC, Last updated: 25/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets
PRAC, Last updated: 19/03/2021 -
List item
News: Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues
PRAC, Last updated: 16/03/2021 -
List item
News: Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion
PRAC, Last updated: 12/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update
PRAC, Last updated: 11/03/2021 -
List item
News: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria
PRAC, Last updated: 10/03/2021